MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 26.03.2026
Aileron Therapeutics P/B 2011-2026 | ALRN
P/B Jährlich Aileron Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 0.702 | 0.277 | 0.358 | 0.0432 | 4.91 | 1.09 | 0.812 | 1.44 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.91 | 0.0432 | 1.21 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
Cerus Corporation
CERS
|
7.63 | $ 2.68 | -1.65 % | $ 511 M |  USA |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
BioNTech SE
BNTX
|
5.29 | $ 96.56 | -2.81 % | $ 27.2 B | Germany |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M |  Britain |
 |
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | France |
 |
Edesa Biotech
EDSA
|
3.07 | $ 15.71 | -2.48 % | $ 50.2 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Evogene Ltd.
EVGN
|
0.869 | $ 0.78 | 4.15 % | $ 27.9 M |  Israel |
 |
Athira Pharma
ATHA
|
0.036 | - | - | $ 269 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | Israel |
 |
AstraZeneca PLC
AZN
|
2.07 | - | - | $ 96.9 B | Britain |
 |
Atreca
BCEL
|
0.625 | - | -11.76 % | $ 5.79 M | USA |
 |
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
0.0645 | - | - | $ 2.46 M | Israel |
 |
Calithera Biosciences
CALA
|
19.6 | - | -10.95 % | $ 876 K | USA |
 |
Genmab A/S
GMAB
|
8.26 | - | - | $ 16.9 B |  Danmark |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
CymaBay Therapeutics
CBAY
|
11.7 | - | - | $ 3.45 B | USA |
 |
ChemoCentryx
CCXI
|
0.00635 | - | - | $ 3.74 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
1.85 | - | - | $ 1.87 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
ImmuCell Corporation
ICCC
|
2.15 | $ 8.78 | 0.71 % | $ 79.2 M | USA |
 |
Caladrius Biosciences
CLBS
|
0.122 | - | -16.75 % | $ 25.8 M | USA |
 |
Innoviva
INVA
|
0.992 | $ 22.78 | -0.91 % | $ 1.54 B | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
0.759 | - | - | $ 231 M | USA |
 |
Innate Pharma S.A.
IPHA
|
1.36 | - | - | $ 235 M | France |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M |  Canada |
 |
ACADIA Pharmaceuticals
ACAD
|
4.36 | $ 22.3 | 0.5 % | $ 3.7 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.815 | - | -2.5 % | $ 5.88 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
Jaguar Health
JAGX
|
-0.0512 | $ 2.83 | -13.08 % | $ 6.6 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
3.42 | - | - | $ 2.18 B | USA |
 |
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | USA |
 |
Cardiff Oncology
CRDF
|
2.56 | - | - | $ 109 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.9 | - | - | $ 2.02 B | USA |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
-308 | $ 26.7 | 0.15 % | $ 1.44 B | Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | - | - | $ 5.75 M | Israel |
 |
Eiger BioPharmaceuticals
EIGR
|
-0.215 | - | -9.21 % | $ 2.55 M | USA |
 |
Kamada Ltd.
KMDA
|
0.85 | $ 8.24 | -0.62 % | $ 260 M | Israel |
 |
Eloxx Pharmaceuticals
ELOX
|
-0.577 | - | -5.68 % | $ 8.28 M | USA |